Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS).
Miodrag JanićManfredi RizzoFrancesco CosentinoAnca Pantea StoianMojca LunderMišo ŠabovićAndrej JanežPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
ClinicalTrials.gov Identifier: NCT05147896.
Keyphrases